Article
Baseline Cystatin C measurement is a potent predictor of adverse cardiovascular outcomes following ACS: A PROVE IT-TIMI 22 analysis
All Scholarly Works
Document Type
Presentations, Research
Publication Date
11-1-2006
Citation Information
American Heart Association Scientific Sessions. Abstract online at http://www.scienceondemand.org.